Cargando…
A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo
The gut microbiome has a recognized role in Non-alcoholic fatty liver disease (NAFLD) and associated comorbidities such as Type-2 diabetes and obesity. Stool transplantation has been shown to improve disease by restoring endothelial function and insulin signaling. However, more patient-friendly trea...
Autores principales: | Pinheiro, Iris, Barberá, Aurora, Raurell, Imma, Estrella, Federico, de Leeuw, Marcel, Bolca, Selin, Gottardi, Davide, Horscroft, Nigel, Possemiers, Sam, Salcedo, María Teresa, Genescà, Joan, Martell, María, Augustin, Salvador |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175091/ https://www.ncbi.nlm.nih.gov/pubmed/35625927 http://dx.doi.org/10.3390/biomedicines10051191 |
Ejemplares similares
-
Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH
por: Bravo, Miren, et al.
Publicado: (2019) -
Liver steatosis induces portal hypertension regardless of fibrosis in patients with NAFLD: A proof of concept case report
por: Rivera-Esteban, Jesús, et al.
Publicado: (2022) -
Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH
por: Bravo, Miren, et al.
Publicado: (2021) -
Inhibition of Neuronal Apoptosis and Axonal Regression Ameliorates Sympathetic Atrophy and Hemodynamic Alterations in Portal Hypertensive Rats
por: Ezkurdia, Nahia, et al.
Publicado: (2014) -
A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats
por: Rodríguez, Sarai, et al.
Publicado: (2017)